In line with its mission, HVI is collaborating with international research organisations to address a number of issues related to ensuring access to future HIV vaccines and with countries to develop policies and strategies for use and scale-up of future HIV vaccines.
HVI is committed to engaging the scientific community as well as the community involved in promoting HIV vaccines at the local grassroot level, on issues related to assessing and employing potential vaccination strategies. HVI also strives to create an enabling environment for research institutions and to act as an honest impartial broker.
HVI is involved in a number of studies and consultations, which have been chosen not only to resolve research questions, but also to stimulate interest in the vaccine research community. To accelerate industry investment and prepare for future access, it is essential for WHO-UNAIDS to catalyse discussions on these issues.
Examples of on-going studies:
Delivery and cost-effectiveness study: HVI is involved in a study to assess the potential logistics, practical and political issues related to the delivery of future HIV vaccines. An assessment of Brazil, Thailand and Kenya will be made as to their capacity to deliver a future HIV vaccine to chosen target populations. A cost-effectiveness analysis which will estimate the cost-effectiveness for different vaccination strategies in three different countries will follow. Cost information will be collected in Brazil, Thailand and Kenya.
Collaborators: Emory University, Wayne State University and local institutions in each of the three countries, yet to be finalised.